Business
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is thrilled to announce that BioGene Therapeutics Inc. ("BioGene"), a majority-owned subsidiary of the Company, has officially launched its new website. BioGene is a Texas-based life sciences company focused
About this update from Preveceutical Medical Inc
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is thrilled to announce that BioGene Therapeutics Inc. ("BioGene"), a majority-owned subsidiary of the Company, has officially launched its new website. BioGene is a Texas-based life sciences company focused on advancing innovative therapies in metabolic health and gene-based treatments.","length":601,"tagName":"p"},{"type":"text","content":"The newly launched website is a pivotal component of BioGene's growth strategy, designed to provide comprehensive information about the company's cutting-edge research and development initiatives. It serves as a resource for stakeholders, potential partners, and the scientific community to stay informed about BioGene's advancements and contributions to the field of life sciences.","length":394,"tagName":"p"},{"type":"text","content":"BioGene is currently engaged in groundbreaking research into GLP-1 receptor agonists and advanced diabetes treatments through a wholly-owned subsidiary, BioGene Australia. This includes exploring gene therapies designed to address the growing global diabetes and obesity crisis, positioning BioGene at the forefront of developing next-generation therapeutic solutions.","length":368,"tagName":"p"},{"type":"text","content":"PreveCeutical and BioGene are dedicated to making significant strides in medical research and delivering innovative treatments that improve health outcomes globally. The launch of BioGene's new website marks a significant milestone in enhancing the company's digital presence and fostering greater engagement with the broader scientific and medical communities.","length":369,"tagName":"p"},{"type":"text","content":"About BioGene Therapeutics Inc.","length":31,"tagName":"p"},{"type":"text","content":"BioGene, a Texas-based life sciences company, focuses on metabolic health and gene therapies. Its wholly-owned subsidiary, BioGene Australia, benefits from Australia's R&D tax cashback incentive, helping in research and development. The subsidiary focuses on GLP-1 receptor agonists and advanced diabetes treatments to a...